We provide comprehensive information about heart failure, including risk factors, signs, symptoms, causes, stages, and treatment options. We also provide guidance on science-based nutrition, exercise and stress management for a heart-healthy life.
May 27, 2025 — CeleCor Therapeutics has successfully completed a Phase 3 clinical trial of its investigational heart attack drug, DisaggproT (zalunfiban), marking a potential breakthrough in emergency cardiac care. …